(Q40435387)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

20 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells (English)

1 reference

20 September 2017

0 references

Ya-Lin Chiu

1

1 reference

20 September 2017

Vanessa B Soros

2

1 reference

20 September 2017

Jason F Kreisberg

3

1 reference

20 September 2017

Kim Stopak

4

1 reference

20 September 2017

Wes Yonemoto

5

1 reference

20 September 2017

Warner C Greene

6

1 reference

20 September 2017

language of work or name

English

0 references

publication date

13 April 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

435

1 reference

20 September 2017

issue

7038

1 reference

20 September 2017

page(s)

108-114

1 reference

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

DNA deamination mediates innate immunity to retroviral infection

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

Hypermutation of HIV-1 DNA in the Absence of the Vif Protein

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

HIV-1 Vif Blocks the Antiviral Activity of APOBEC3G by Impairing Both Its Translation and Intracellular Stability

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

Molecular mechanisms of apolipoprotein B mRNA editing

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

Inhibition of hepatitis B virus replication by APOBEC3G.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

Cytidine deamination of retroviral DNA by diverse APOBEC proteins

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03493

7 January 2021

Identifiers

DOI

10.1038/NATURE03493

1 reference

Dimensions Publication ID

20 September 2017

1006468618

0 references

1 reference